ASMB Assembly Biosciences, Inc.
Healthcare$28.34+6.94%ClosedMarket Cap: $450.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.41
P/S
6.33
EV/EBITDA
-35.85
DCF Value
$-65.18
FCF Yield
-8.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.2%
Operating Margin
-19.1%
Net Margin
-9.0%
ROE
-4.2%
ROA
-2.7%
ROIC
-6.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.2M | 99.7% | $-11.4M | $-9.1M | $— | — |
| Q4 null | $42.5M | 99.9% | $19.8M | $22.1M | $— | — |
| FY null | $72.3M | 99.8% | $-12.1M | $-6.1M | $— | — |
| Q3 null | $10.8M | 100.0% | $-10.9M | $-9.2M | $— | — |
| Q2 null | $9.6M | -67.5% | $-11.1M | $-10.2M | $— | — |
| Q1 null | $9.4M | 100.0% | $-9.9M | $-8.8M | $— | — |
| Q4 null | $7.4M | -94.1% | $-11.5M | $-10.3M | $— | — |
| FY null | $28.5M | 100.0% | $-45.4M | $-40.2M | $— | — |
| Q3 null | $6.8M | 100.0% | $-11.0M | $-9.6M | $— | — |
| Q2 null | $8.5M | 99.6% | $-12.2M | $-11.2M | $— | — |
| Q1 null | $5.8M | 99.4% | $-10.7M | $-9.1M | $— | — |
| Q4 2023 | $7.2M | 98.8% | $-12.6M | $-11.0M | $-2.00 | — |